Cohen Klingenstein LLC - Merck & Co Inc ownership

Merck & Co Inc's ticker is MRK and the CUSIP is 589331107. A total of 14 filers reported holding Merck & Co Inc in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
Cohen Klingenstein LLC ownership history of Merck & Co Inc
ValueSharesWeighting
Q3 2023$15,620,089
-10.9%
151,725
-0.1%
0.71%
-6.7%
Q2 2023$17,531,433
+7.2%
151,932
-1.2%
0.76%
-1.2%
Q1 2023$16,355,547
-4.8%
153,732
-0.7%
0.77%
-11.1%
Q4 2022$17,172,508
+28.2%
154,777
-0.5%
0.86%
+21.7%
Q3 2022$13,397,000
-5.5%
155,561
+0.0%
0.71%
-0.1%
Q2 2022$14,182,000
+9.9%
155,560
-1.1%
0.71%
+32.6%
Q1 2022$12,901,000
+7.1%
157,2350.0%0.54%
+12.4%
Q4 2021$12,050,000
-11.0%
157,235
-12.8%
0.48%
-19.4%
Q3 2021$13,539,000
-15.0%
180,249
-12.0%
0.59%
-13.6%
Q2 2021$15,937,000
+0.9%
204,9260.0%0.68%
-6.0%
Q1 2021$15,798,000
-5.8%
204,9260.0%0.73%
-13.0%
Q4 2020$16,763,000
-1.4%
204,9260.0%0.84%
-12.5%
Q3 2020$16,999,000
+7.3%
204,9260.0%0.96%
-1.4%
Q2 2020$15,847,000
+0.5%
204,9260.0%0.97%
-16.6%
Q1 2020$15,767,000
-15.4%
204,9260.0%1.17%
+7.7%
Q4 2019$18,638,000
+8.0%
204,9260.0%1.08%
-0.1%
Q3 2019$17,251,000
+13.1%
204,926
+12.6%
1.08%
-0.3%
Q2 2019$15,254,000
-10.7%
181,926
-11.4%
1.09%
-8.7%
Q1 2019$17,075,000
+155.5%
205,300
+134.7%
1.19%
+17.8%
Q4 2018$6,684,000
+7.7%
87,4750.0%1.01%
+28.0%
Q3 2018$6,205,000
+16.9%
87,4750.0%0.79%
+8.7%
Q2 2018$5,310,000
+11.4%
87,4750.0%0.73%
+7.4%
Q1 2018$4,765,000
-3.2%
87,4750.0%0.68%
-3.4%
Q4 2017$4,922,000
-12.1%
87,4750.0%0.70%
-17.3%
Q3 2017$5,601,000
-0.1%
87,4750.0%0.85%
-3.1%
Q2 2017$5,606,000
+0.9%
87,4750.0%0.87%
-1.9%
Q1 2017$5,558,000
+7.9%
87,4750.0%0.89%
+1.1%
Q4 2016$5,150,000
-5.7%
87,4750.0%0.88%
-7.2%
Q3 2016$5,459,000
+32.6%
87,475
+22.4%
0.95%
+25.2%
Q2 2016$4,118,000
+8.9%
71,4750.0%0.76%
+6.2%
Q1 2016$3,782,000
+0.2%
71,4750.0%0.71%
+1.3%
Q4 2015$3,775,000
+6.9%
71,4750.0%0.70%
+1.1%
Q3 2015$3,530,000
-13.2%
71,4750.0%0.70%
-4.9%
Q2 2015$4,069,000
-0.9%
71,4750.0%0.73%
-2.4%
Q1 2015$4,108,000
+1.2%
71,4750.0%0.75%
-1.6%
Q4 2014$4,059,000
-4.2%
71,4750.0%0.76%
+2.0%
Q3 2014$4,237,000
+2.5%
71,4750.0%0.75%
-5.3%
Q2 2014$4,135,000
+1.9%
71,4750.0%0.79%
-2.1%
Q1 2014$4,058,000
+13.4%
71,4750.0%0.81%
+13.4%
Q4 2013$3,577,000
-2.0%
71,475
-6.8%
0.71%
-10.7%
Q3 2013$3,649,000
+2.5%
76,6550.0%0.80%
-3.9%
Q2 2013$3,561,00076,6550.83%
Other shareholders
Merck & Co Inc shareholders Q1 2022
NameSharesValueWeighting ↓
KAHN BROTHERS GROUP INC 1,010,927$53,397,196,0009.54%
Bruce & Co., Inc. 259,400$13,701,0003.72%
LAU ASSOCIATES LLC 57,252$3,024,0003.26%
BENNICAS & ASSOCIATES, INC. 60,008$3,170,0003.06%
MARSHWINDS ADVISORY CO 68,699$3,629,0001.89%
BONTEMPO OHLY CAPITAL MGMT LLC 37,207$1,965,0001.86%
Taylor, Cottrill LLC 68,230$3,604,0001.86%
Grassi Investment Management 132,363$6,991,0001.43%
Wills Financial Group, Inc. 24,295$1,283,0001.13%
Westbourne Investment Advisors, Inc. 19,195$1,014,0000.98%
View complete list of Merck & Co Inc shareholders